EPISODE 099
Anne Sissel, vice president of ventures at Baxter International, followed her love of numbers into Medtech. But she quickly came to appreciate just how powerful an impact start-up innovation can have on treating the sick. Now she’s working on behalf of Baxter Ventures to find young companies that need capital and guidance. Sissel will lead a panel about the strategic-start-up relationship at the upcoming Medtech Conference on May 31.
Podcast Guest
Anne Sissel
VP, Ventures
Baxter International
Anne Sissel is the Vice President and Head of Baxter Ventures. Baxter Ventures is the corporate venture capital fund of Baxter International, investing in companies with innovative technologies, products and/or therapies.
Prior to Baxter, Anne was on the executive team for Veracyte, Inc. leading the finance and business development organization from early discovery through commercialization. Prior to Veracyte, Anne worked in the Investment Banking Division of Goldman, Sachs & Co. in New York and San Francisco. Anne has completed over $200bn in financing and M&A transactions for clients in the healthcare industry.
Anne holds an MBA from the Wharton School of the University of Pennsylvania and a BS in Finance from Indiana University. She was selected to Crain’s Chicago Business Top 40 Under 40 in 2016. Anne’s current Board and Observation roles representing Baxter include: Kit Check, Medasense, TVA Medical and VitalConnect.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.